Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 8.13
(0.62%)
CNY 8.13
(0.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 369.99 Million CNY | -11.47% |
| 2022 | 417.93 Million CNY | -33.51% |
| 2021 | 628.53 Million CNY | -6.09% |
| 2020 | 669.28 Million CNY | -15.67% |
| 2019 | 793.62 Million CNY | 12.53% |
| 2018 | 705.26 Million CNY | 18.64% |
| 2017 | 594.46 Million CNY | 160.88% |
| 2016 | 227.87 Million CNY | -16.31% |
| 2015 | 272.26 Million CNY | -22.64% |
| 2014 | 351.95 Million CNY | 6.98% |
| 2013 | 328.98 Million CNY | 35.47% |
| 2012 | 242.84 Million CNY | 68.37% |
| 2011 | 144.23 Million CNY | 115.39% |
| 2010 | 66.96 Million CNY | -19.57% |
| 2009 | 83.26 Million CNY | 7.72% |
| 2008 | 77.29 Million CNY | -28.6% |
| 2007 | 108.25 Million CNY | -15.55% |
| 2006 | 128.18 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 326.25 Million CNY | -11.82% |
| 2024 Q3 | 324.6 Million CNY | 5.08% |
| 2024 Q2 | 308.89 Million CNY | -5.32% |
| 2023 Q4 | 369.99 Million CNY | 0.23% |
| 2023 Q2 | 364.17 Million CNY | -1.02% |
| 2023 Q1 | 367.93 Million CNY | -11.96% |
| 2023 FY | 369.99 Million CNY | -11.47% |
| 2023 Q3 | 369.13 Million CNY | 1.36% |
| 2022 Q2 | 482.63 Million CNY | -10.72% |
| 2022 Q1 | 540.6 Million CNY | -13.99% |
| 2022 FY | 417.93 Million CNY | -33.51% |
| 2022 Q4 | 417.93 Million CNY | -15.06% |
| 2022 Q3 | 492.01 Million CNY | 1.94% |
| 2021 FY | 628.53 Million CNY | -6.09% |
| 2021 Q3 | 574.62 Million CNY | -12.14% |
| 2021 Q2 | 654.06 Million CNY | 7.1% |
| 2021 Q4 | 628.53 Million CNY | 9.38% |
| 2021 Q1 | 610.71 Million CNY | -8.75% |
| 2020 Q1 | 738.36 Million CNY | -6.96% |
| 2020 Q3 | 571.7 Million CNY | -18.17% |
| 2020 Q4 | 669.28 Million CNY | 17.07% |
| 2020 FY | 669.28 Million CNY | -15.67% |
| 2020 Q2 | 698.63 Million CNY | -5.38% |
| 2019 Q2 | 870.06 Million CNY | -2.94% |
| 2019 Q4 | 793.62 Million CNY | -5.34% |
| 2019 FY | 793.62 Million CNY | 12.53% |
| 2019 Q1 | 896.4 Million CNY | 27.1% |
| 2019 Q3 | 838.42 Million CNY | -3.64% |
| 2018 Q1 | 640.09 Million CNY | 7.68% |
| 2018 FY | 705.26 Million CNY | 18.64% |
| 2018 Q2 | 631.22 Million CNY | -1.39% |
| 2018 Q3 | 693.54 Million CNY | 9.87% |
| 2018 Q4 | 705.26 Million CNY | 1.69% |
| 2017 Q1 | 228.25 Million CNY | 0.17% |
| 2017 Q4 | 594.46 Million CNY | -0.78% |
| 2017 FY | 594.46 Million CNY | 160.88% |
| 2017 Q3 | 599.16 Million CNY | 110.76% |
| 2017 Q2 | 284.29 Million CNY | 24.55% |
| 2016 FY | 227.87 Million CNY | -16.31% |
| 2016 Q4 | 227.87 Million CNY | 16.47% |
| 2016 Q3 | 195.64 Million CNY | 7.56% |
| 2016 Q1 | 225.55 Million CNY | -17.16% |
| 2016 Q2 | 181.88 Million CNY | -19.36% |
| 2015 Q4 | 272.26 Million CNY | 54.2% |
| 2015 FY | 272.26 Million CNY | -22.64% |
| 2015 Q2 | 240.29 Million CNY | -20.61% |
| 2015 Q3 | 176.56 Million CNY | -26.52% |
| 2015 Q1 | 302.69 Million CNY | -14.0% |
| 2014 FY | 351.95 Million CNY | 6.98% |
| 2014 Q4 | 351.95 Million CNY | 46.19% |
| 2014 Q3 | 240.75 Million CNY | -16.93% |
| 2014 Q2 | 289.82 Million CNY | 1.22% |
| 2014 Q1 | 286.33 Million CNY | -12.96% |
| 2013 FY | 328.98 Million CNY | 35.47% |
| 2013 Q1 | 280.03 Million CNY | 15.32% |
| 2013 Q2 | 301.58 Million CNY | 7.7% |
| 2013 Q3 | 260.23 Million CNY | -13.71% |
| 2013 Q4 | 328.98 Million CNY | 26.42% |
| 2012 Q3 | 251.67 Million CNY | -2.35% |
| 2012 Q1 | 179.93 Million CNY | 24.75% |
| 2012 Q4 | 242.84 Million CNY | -3.51% |
| 2012 FY | 242.84 Million CNY | 68.37% |
| 2012 Q2 | 257.71 Million CNY | 43.23% |
| 2011 FY | 144.23 Million CNY | 115.39% |
| 2011 Q3 | 103.82 Million CNY | 43.78% |
| 2011 Q4 | 144.23 Million CNY | 38.92% |
| 2011 Q2 | 72.21 Million CNY | 0.33% |
| 2011 Q1 | 71.97 Million CNY | 7.48% |
| 2010 Q2 | 55.55 Million CNY | -6.12% |
| 2010 FY | 66.96 Million CNY | -19.57% |
| 2010 Q3 | 54.56 Million CNY | -1.79% |
| 2010 Q4 | 66.96 Million CNY | 22.72% |
| 2010 Q1 | 59.18 Million CNY | -28.92% |
| 2009 Q4 | 83.26 Million CNY | 54.05% |
| 2009 FY | 83.26 Million CNY | 7.72% |
| 2009 Q2 | 77.52 Million CNY | 0.0% |
| 2009 Q3 | 54.04 Million CNY | -30.29% |
| 2008 Q4 | 77.29 Million CNY | 0.0% |
| 2008 FY | 77.29 Million CNY | -28.6% |
| 2007 FY | 108.25 Million CNY | -15.55% |
| 2006 FY | 128.18 Million CNY | 0.0% |